Human monocytic tumor cells of the U937 cell line contain substantial quantities of two neutrophil neutral proteinases, elastase and cathepsin G, raising the question of whether their presence reflects an expression of transformation or whether normal monocytes undergo a developmental stage in which they produce certain neutrophil proteinases. To address this issue, we examined U937 cells for production of collagenase, since human alveolar macrophages release fibroblast-like collagenase, an enzyme that is distinct from neutrophil collagenase. Using an immunoassay that utilized antibody to skin fibroblast collagenase, we found that U937 cells secreted barely detectable quantities of enzyme, 10-12 ng/10' cells per 24 h, under basal conditions. Upon incubation with 10 nM 12-o-tetradecanoyl-phorbol-13-acetate (TPA), however, collagenase release increased 200-fold, comparable to the amount secreted by phorbol-stimulated human fibroblasts. Metabolic labeling and immunoprecipitation confirmed the enhanced synthesis of U937 cell collagenase upon TPA exposure. This enzyme activity further resembled fibroblast collagenase and differed from neutrophil collagenase by exhibiting preferential cleavage of monomeric type III collagen relative to type I. As previously observed with human alveolar macrophages, U937 cells also released a protein identical to the collagenase inhibitor produced by human skin fibroblasts, a molecule not associated with neutrophils. Release of this inhibitor increased 10-fold with TPA exposure.
Introduction U937 cells are a continuous line of human cells of committed monocytic origin. They have attracted considerable attention because of widespread interest in mononuclear phagocytes and because they can be grown readily in culture and are susceptible to manipulations that result in their differentiation and acquisition of phenotypic characteristics of mature monocytes (1) (2) (3) .
We and others have reported that U937 cells contain substantial amounts of neutrophil elastase and cathepsin G, enzymes previously found only in polymorphonuclear leukocytes (4) (5) (6) . These findings raised the question of whether U937 cells depict the proteinase profile of normal immature monocytes, which may have a developmental stage involving the production of certain neutrophil proteinases, or whether these cells have an anomalous profile of proteinases. Since human alveolar macrophages secrete a collagenase and a collagenase inhibitor that are immunologically and functionally indistinguishable from the collagenase and collagenase inhibitor released by human fibroblasts (7) , and distinct from any such proteins contained within neutrophils, we thought it would be ofinterest to examine U937 cells for the production of collagenolytic activity.
We have observed that U937 cells in their basal state produced barely detectable amounts of collagenase, but after exposure to 12-o-tetradecanoyl-phorbol-I3-acetate (TPA)' and subsequent cellular differentiation, there was a 200-fold increase in the secretion of this enzyme. By kinetic and immunologic criteria, the collagenase activity appeared to be identical to the collagenase elaborated by human alveolar macrophages, and unrelated to neutrophil collagenase. U937 cells also released the collagenase inhibitor typically produced by fibroblasts (8, 9) and macrophages (7, 10 ), a protein not associated with neutrophils.
Whereas U937 cells produced essentially no collagenase in the basal state, the collagenase inhibitor was released by undifferentiated cells in significant amounts, but the levels of inhibitor nevertheless increased 10-fold upon exposure ofthe cells to TPA.
Concomitant with the effects of TPA upon collagenase and collagenase inhibitor expression, there were marked reductions in cellular elastase and cathepsin G activities. These findings indicate that differentiation of U937 cells is accompanied by a shift from a neutrophilic to a monocytic profile of neutral proteinases.
Methods
Reagents. Dibutyryladenosine 3'5'-cyclic monophosphate (cAMP), TPA, formyl-methionyl-leucyl-phenylalanine (fMLP), succinyl-alanyl-alanylalanine-p-nitroanilide, succinyl-alanyl-alanyl-prolyl-phenylalanyl-p-nitroanilide, and bovine pancreatic trypsin were obtained from Sigma versity Medical Center, Durham, NC, were cultured in RPMI 1640 supplemented with 10% fetal calfserum and 2 mM L-glutamine, as previously described (4) . According to the experimental protocol, cell culture medium included either TPA (1.6 X I01o-1.6 X 10-6 M), cAMP (10-M) or vitamin D3 (I0-'°-10-6 M). TPA was added to culture medium immediately before use from a 1.6 X 10-3 M TPA in dimethyl sulfoxide stock solution that was stored at -20'C. cAMP was dissolved into culture medium directly. Vitamin D3 was solubilized in 95% ethanol. At the conclusion of the incubation period, cell-conditioned medium was collected by centrifuging cultures, 200 g for 10 min, and removing the supernatant. In the case of adherent cells, as occurred with TPA exposure, cells were collected by scraping after a 10-min period on ice with cold phosphate-buffered saline, pH 7.5. To prepare cell extracts, cells were adjusted to 5 X 107/ml, then subjected to three cycles of freeze-thawing (dry ice-methanol) and sonification on ice (2-min cycles at 0.5 setting; Dismembranator; Fisher Scientific Co., Pittsburgh, PA).
Cell-conditioned medium. For studies ofcollagenase and collagenase inhibitor production using TPA as a differentiating agent, conditioned media were collected for time periods up to 72 h. When cAMP was used to induce differentiation, U937 cells were exposed to this agent for 72 h, after which the conditioned medium was removed and replaced with fresh medium for another 72 h. In studies employing vitamin D3 for differentiation, culture medium was changed daily for 6 d. After collection, all conditioned media samples were adjusted to 0.05 M Tris, pH 7.5, containing 0.01 M CaC12, and then analyzed for collagenase and collagenase inhibitor.
Assay procedures. Elastase activity was measured by the solubilization of "4C-labeled elastin (I 1). Cathepsin G activity was determined using succinyl-alanyl-alanyl-prolyl-phenylalanyl-p-nitroanilide as substrate and by monitoring absorbance at 410 nm (5, 12) . Purified human leukocyte elastase (13) and cathepsin G (14, 15) were used as standards for these assays. Collagenase and collagenase inhibitor levels were quantified by enzyme-linked immunosorbent assays (ELISAs) (9, 16) . The collagenase ELISA uses polyclonal antibody directed against human skin fibroblast collagenase that does not cross-react with the collagenolytic enzyme produced by human polymorphonuclear leukocytes (16) . Functional collagenase activity was monitored by the solubilization of reconstituted guinea pig skin type I collagen fibrils which had been biosynthetically labeled with ["C]glycine (17) . Since collagenase is secreted as a zymogen (18, 19) and the conditioned medium contained 10% fetal calf serum, enzyme activation required exposure to large amounts of trypsin. Accordingly, trypsin titrations were performed using a range of concentrations from 0.5 to 50 Mg of trypsin/100 Ml of conditioned medium to ensure maximal procollagenase activation. Generally, 10-20 Mg oftrypsin per sample of conditioned medium incubated at room temperature for 10 min produced optimal collagenase activity. The action oftrypsin was stopped by the addition of a fivefold molar excess of soybean trypsin inhibitor.
DNA content was determined as described by Burton (20) . Total protein synthesis was measured by exposing cultures to serum-free medium containing [3H]leucine, 100 MCi/ml, for 6 h followed by precipitation in cold 20% trichloroacetic acid. Cell numbers were quantified by a particle counter ( were added. The mixtures were held on ice for 10 min and then centrifuged at 10,000 g for 10 min. 6 Ml of either anticollagenase IgG (18, 19) or anticollagenase inhibitor IgG (8, 9) mercaptoethanol was added to a final concentration of 2% (vol/vol) and then the samples were boiled for 3-4 min. Autoradiography was performed by subjecting the samples to polyacrylamide gel electrophoresis (23) , after which the slab gels were dried and then exposed to XAR-5 X-Omat AR film (Eastman Kodak Co., Rochester, NY) at -70°C.
Kinetic studies of U937 collagenase activity. U937 cell-conditioned medium was tested for collagenolytic activity against monomeric collagen types I, II, and III in solution at 25°C. Values for the Michaelis constant (K.) and relative rates of catalysis against these collagen types were determined by incubating reaction mixtures containing increasing concentrations of substrate with trypsin-activated conditioned medium. The TC^digestion products were then quantified by densitometric scanning of stained polyacrylamide slab gels (24) and the data plotted according to the method of Lineweaver and Burk.
Stoichiometry ofcollagenase inhibitor activity. Collagenase inhibitor activity could not be quantified by direct assay of serum-free conditioned media because of the high levels of collagenase concomitantly secreted after TPA exposure and the tendency for zymogen activation under serum-free conditions. Therefore serum-containing TPA-conditioned media were employed, thus preventing proteolytic activation of procollagenase and subsequent binding to inhibitor. In order to assay such media for inhibitory activity, however, collagenase inhibitor had to be separated from both procollagenase and a2-macroglobulin. To accomplish this, 500 ml of TPA-conditioned medium was subjected to 0-60% ammonium sulfate precipitation, resuspended in 0.01 M Tris, pH 7.5, containing 0.0001 M CaC12, and dialyzed against several changes of this buffer. The 0-60% fraction was then applied to a 10 X 2.5-cm column of carboxymethylcellulose (CM 52; Whatman Inc., Clifton, NJ). Collagenase inhibitor and a2-macroglobulin do not bind to this matrix while procollagenase adheres tightly (8, 18) . The fall-through fractions were pooled, dialyzed against 0.05 M Tris, pH 7.5, and applied to a 10 X 2.5-cm column of phosphocellulose (P-li; Whatman, Inc.). Collagenase inhibitor binds avidly to this matrix, whereas armacroglobulin falls through (8) . The (9) .
Results
Collagenase and collagenase inhibitor. U937 cells were placed in culture for 72 h either in the presence or absence of TPA, and the conditioned media was analyzed for collagenase and collagenase inhibitor by ELISAs for each protein (9, 16) . As shown in Fig. 1 200- fold that of basal levels. Such quantities equal or surpass the collagenase production of phorbol-stimulated normal human macrophages (7) and fibroblasts (25) . The dose response to TPA paralleled the acquisition by U937 cells of other monocytic markers of differentiation (26); maximal collagenase expression was reached at 10-8 M TPA.
Whereas U937 cells produced essentially no collagenase in the basal state, the collagenase inhibitory protein was released by undifferentiated cells in significant amounts (Fig. 1 B) , -12 ng/,g DNA per 72 h (50 ng/106 cells per d), levels which are 30-50% of the basal secretory rates of normal alveolar macrophages in culture (7) . Nevertheless, upon exposure to TPA, inhibitor production was augmented 10-fold, reaching levels ( 120 ng/tig DNA per 72 h; 500 ng/106 cells per d) comparable to phorbol-stimulated macrophages (7) although less than the amount secreted by stimulated fibroblasts (2-3 Ug/106 cells per d; [25] ). The dose response of collagenase inhibitor production to TPA mirrored that of collagenase, also reaching maximum values at 10-8 M concentration of the differentiating agent.
The time course ofTPA's effect upon U937 collagenase and collagenase inhibitor production is shown in Fig. 2 . An increase in the amounts of both proteins secreted into cell-conditioned media was apparent by 8-16 h after the start of TPA exposure. As also shown in Fig. 1 , release of inhibitor by U937 cells in their basal state exceeded that of collagenase. However, after cellular differentiation by TPA, both the fold-stimulation and TPA CM) Figure 1 . Dose response of U937 cell collagenase (A) and collagenase inhibitor (B) production after exposure to TPA. U937 cells (-5 X 10/2 ml of medium) were incubated in culture medium containing various concentrations of TPA for 72 h. Collagenase and collagenase inhibitor in the cell-conditioned media were then quantified by ELISA. The actual TPA concentration is 1.6 times the molarity shown in the figure (e.g., 1.6 X 108 M, etc.) . Fig. 3 , each specific antibody precipitated a protein species of identical electrophoretic mobility to either pure procollagenase (Fig. 3 A, lanes 2 and 5) or pure collagenase inhibitor (Fig. 3 B, lanes I and 2) . The doublet nature of the immunoprecipitated procollagenase (18, 19) and the characteristically broad staining pattern of the inhibitor (8, 9) were readily apparent. Furthermore, comparison of metabolically labeled conditioned media samples from U937 cells in their basal state with those obtained after the induction of cellular differentiation (Fig. 3 A, U937 cell-conditioned media contained collagenolytic activity that cleaved type I, II, and III collagens in a manner characteristic of mammalian collagenases. At 250C, only a single three-fourths/one-fourth cleavage was observed, producing typical three-fourths-length TCA and one-fourth-length TCB fragments (not shown). As shown in Table I , the affinity of U937 collagenase for human collagen types I-III was similar, Km = 0.6-1.9 ,uM, values indistinguishable from those displayed by human alveolar macrophage and skin fibroblast collagenases (7, 24 oftype II cleavage, features also exhibited by alveolar macrophage and skin fibroblast enzymes. Selective cleavage of type I collagen monomers as compared with type III, a distinguishing feature of neutrophil collagenase activity (27) , was never observed in (Table II) . Chemotaxis toJMLP. Although vitamin D3 and cAMP exerted only inconsistent and small effects on collagenase and collagenase inhibitor production, both agents caused a marked increase in the chemotactic responsiveness ofU937 cells to fMLP, consistent with the observations of others ([1], Table III ). The chemotactic responsiveness of TPA-treated cells was difficult to assess because exposure to this agent caused the cells to become tightly adherent, requiring vigorous manipulation in order to harvest them for use in chemotaxis assays, thus possibly causing cellular injury. In any event, it is clear that the maturational Results are means of a minimum of two separate studies done in duplicate. Elastase and cathepsin G activities of cell extracts were determined as described under Methods. changes induced by various differentiating agents are quite distinct as regards the capacity for alteration of the neutral proteinase profile of U937 cells and for promotion of responsiveness to chemotactic stimuli (Table IV) .
Discussion
Recently, we and others reported that U937 cells in their basal undifferentiated state contain substantial amounts ofneutrophil elastase and cathepsin G, two serine neutral proteinases previously associated only with neutrophils (4-6). These findings raised the question of whether U937 cells depict the proteinase profile of normal immature monocytes, which may undergo an early developmental stage involving the production of certain neutrophil proteinases, or whether these enzymes are an expression of transformation. The data in the present report indicate that undifferentiated U937 cells produce negligible amounts of collagenase, but differentiation induced by TPA results in a dramatic increase in collagenase production and the collagenase released by differentiated cells is immunologically and functionally identical to alveolar macrophage collagenase and thus distinct from the collagenolytic enzyme found in neutrophils. Macrophage and neutrophil collagenases are readily distinguished by their opposite selectivities against monomeric type I and III collagens (27) , by their lack of cross-reactivity to monoclonal and polyclonal antibody preparations (30) , and by the fact that neutrophil collagenase is stored within granules (31) while the macrophage enzyme is secreted without significant intracellular storage (7) . Likewise, the collagenase inhibitor elaborated by undifferentiated U937 cells, whose expression is markedly increased by exposure to TPA, is a proven secretory product of alveolar macrophages (7) and is neither contained in nor released from neutrophils (8) . Thus, with respect to proteins changes associated with neutral proteinase production are separable from other features of differentiation, such as chemotactic responsiveness. From these findings one must conclude that caution is necessary in generalizing about the differentiating effects of an agent based upon a particular cell function or feature.
It may be significant that U937 cells in their basal undifferentiated state release collagenase inhibitor in amounts almost comparable to the amounts secreted by normal alveolar macrophages, but release essentially no collagenase. In this regard it is of interest to compare them with cells from another human leukocytic stem cell line, HL-60. HL-60 cells do not express either collagenase or collagenase inhibitor in the basal state; however, when induced to differentiate along a monocytic lineage by phorbol esters or vitamin D3, HL-60 cells secrete large amounts of collagenase inhibitor but still fail to produce collagenase (10). Since HL-60 cells are more immature than U937, having the capacity to develop into either myelocytic or monocytic cells, whereas U937 are committed on the monocytic pathway, it appears that the onset of production of collagenase inhibitor precedes collagenase production in the developing mononuclear phagocyte.
Mononuclear phagocytes have been implicated in the remodeling of extracellular matrix. Among their activities potentially involved in such remodeling is production of collagenase, the enzyme that initiates the cleavage of native collagen (36) and of inhibitory molecules that specifically block this enzyme's catalytic function. A number of studies have demonstrated the release of collagenase activity from animal mononuclear phagocytes (37, 38) and recently these observations have been extended to human peripheral blood monocytes (39) and alveolar macrophages (7) in culture. The production of both collagenase and collagenase inhibitor proteins by alveolar macrophages (7) and by TPA-differentiated U937 cells provide conclusive evidence that human mononuclear phagocytes can directly modulate the turnover of collagen. The expression of collagenase and collagenase inhibitor by mononuclear phagocytes and its implications for the pathogenesis of disease states are currently under investigation.
